Readers Follow an Emergency Room Nurse’s Experiences Saving Lives in New Novel

    NEXT STORY
    Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear Cell Sarcoma of Soft Tissue
    PREV STORY
    Active Biotech’s nomination committee appointed 
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Mustang Bio Announces Opening of CAR T Cell Therapy Manufacturing Facility in Worcester, Mass.

    UMass Medicine Science Park facility to support clinical development and commercialization of CAR T ...

    author_avatar
    NASDAQ Market News

    Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Remains on Track for Commercial Launch by First Quarter 2019

    Completed submission of NDAs for oral and intravenous omadacycline for the treatment of pneumonia ...

    author_avatar
    NASDAQ Market News

    Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing

    Nutra Pharma is announcing the execution of a Letter of Intent for a $4 ...

    author_avatar
    NASDAQ Market News